
Wiebke Schlötelburg
Articles
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Dec 1, 2023 |
jnm.snmjournals.org | Johannes Duell |Andreas Bück |Philipp Hartrampf |Wiebke Schlötelburg
MATERIALS AND METHODSIn this retrospective, single-center study, we included 100 patients (women, 55/100 [55%]; mean age, 66 ± 13 y; age range, 24–86 y) with MZL who had been imaged with [68Ga]Ga-pentixafor as part of routine care (primary staging, 92/100 [92%]; restaging, 8/100 [8%]). In all cases, MZL was histologically confirmed. All subjects provided written consent for the conducted procedures. The local ethics committee waived the need for further approval (number 20220414 01).
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Oct 5, 2023 |
jnm.snmjournals.org | Johannes Duell |Andreas Bück |Philipp Hartrampf |Wiebke Schlötelburg
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma Johannes Duell, Andreas K. Buck, Philipp E. Hartrampf, Wiebke Schlötelburg, Simone Schneid, Alexander Weich, Niklas Dreher, Constantin Lapa, Malte Kircher, Takahiro Higuchi, Samuel Samnick, Sebastian E. Serfling, Markus Raderer, Leo Rasche, Hermann Einsele, Max S. Topp, Aleksander Kosmala, Rudolf A.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →